Pre-treatment of the beta3-adrenergic receptor agonist BRL37344 reduces in vivo myocardial ischemia/reperfusion injury by improving AMPK and SIRT1 activity and by suppressing mTOR and p70S6K signaling pathways

Dilan AŞKIN ÖZEK(Fırat University), Engin Şahna(Dokuz Eylül University)
Brazilian Journal of Pharmaceutical Sciences
January 1, 2023
Cited by 0


Related Papers

No related papers found

Powered by citation graph analysis